ID ABCAC_MOUSE Reviewed; 2595 AA. AC E9Q876; DT 02-JUN-2021, integrated into UniProtKB/Swiss-Prot. DT 05-APR-2011, sequence version 1. DT 27-MAR-2024, entry version 90. DE RecName: Full=Glucosylceramide transporter ABCA12 {ECO:0000305}; DE EC=7.6.2.1 {ECO:0000250|UniProtKB:Q86UK0}; DE AltName: Full=ATP-binding cassette sub-family A member 12 {ECO:0000305}; GN Name=Abca12 {ECO:0000312|MGI:MGI:2676312}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [2] RP DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, AND FUNCTION. RX PubMed=18632686; DOI=10.1093/hmg/ddn204; RA Yanagi T., Akiyama M., Nishihara H., Sakai K., Nishie W., Tanaka S., RA Shimizu H.; RT "Harlequin ichthyosis model mouse reveals alveolar collapse and severe RT fetal skin barrier defects."; RL Hum. Mol. Genet. 17:3075-3083(2008). RN [3] RP DISRUPTION PHENOTYPE, AND FUNCTION. RX PubMed=18957418; DOI=10.1074/jbc.m807377200; RA Zuo Y., Zhuang D.Z., Han R., Isaac G., Tobin J.J., McKee M., Welti R., RA Brissette J.L., Fitzgerald M.L., Freeman M.W.; RT "ABCA12 maintains the epidermal lipid permeability barrier by facilitating RT formation of ceramide linoleic esters."; RL J. Biol. Chem. 283:36624-36635(2008). RN [4] RP MUTAGENESIS OF GLY-1996, AND FUNCTION. RX PubMed=18802465; DOI=10.1371/journal.pgen.1000192; RA Smyth I., Hacking D.F., Hilton A.A., Mukhamedova N., Meikle P.J., Ellis S., RA Satterley K., Slattery K., Collinge J.E., de Graaf C.A., Bahlo M., RA Sviridov D., Kile B.T., Hilton D.J.; RT "A mouse model of harlequin ichthyosis delineates a key role for Abca12 in RT lipid homeostasis."; RL PLoS Genet. 4:e1000192-e1000192(2008). RN [5] RP FUNCTION. RX PubMed=20489143; DOI=10.2353/ajpath.2010.091120; RA Yanagi T., Akiyama M., Nishihara H., Ishikawa J., Sakai K., Miyamura Y., RA Naoe A., Kitahara T., Tanaka S., Shimizu H.; RT "Self-improvement of keratinocyte differentiation defects during skin RT maturation in ABCA12-deficient harlequin ichthyosis model mice."; RL Am. J. Pathol. 177:106-118(2010). RN [6] RP FUNCTION, AND INTERACTION WITH NR1H2 AND ABCA1. RX PubMed=23931754; DOI=10.1016/j.cmet.2013.07.003; RA Fu Y., Mukhamedova N., Ip S., D'Souza W., Henley K.J., DiTommaso T., RA Kesani R., Ditiatkovski M., Jones L., Lane R.M., Jennings G., Smyth I.M., RA Kile B.T., Sviridov D.; RT "ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and RT the development of atherosclerosis."; RL Cell Metab. 18:225-238(2013). RN [7] RP TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND FUNCTION. RX PubMed=24293640; DOI=10.1194/jlr.m044941; RA Haller J.F., Cavallaro P., Hernandez N.J., Dolat L., Soscia S.J., Welti R., RA Grabowski G.A., Fitzgerald M.L., Freeman M.W.; RT "Endogenous beta-glucocerebrosidase activity in Abca12-/- epidermis RT elevates ceramide levels after topical lipid application but does not RT restore barrier function."; RL J. Lipid Res. 55:493-503(2014). RN [8] RP FUNCTION, AND MUTAGENESIS OF 1388-ILE--ARG-1461. RX PubMed=27551807; DOI=10.1371/journal.pone.0161465; RA Zhang L., Ferreyros M., Feng W., Hupe M., Crumrine D.A., Chen J., RA Elias P.M., Holleran W.M., Niswander L., Hohl D., Williams T., RA Torchia E.C., Roop D.R.; RT "Defects in Stratum Corneum Desquamation Are the Predominant Effect of RT Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis."; RL PLoS ONE 11:e0161465-e0161465(2016). RN [9] RP TISSUE SPECIFICITY, AND FUNCTION. RX PubMed=32072744; DOI=10.15252/embr.201948692; RA Ursino G.M., Fu Y., Cottle D.L., Mukhamedova N., Jones L.K., Low H., RA Tham M.S., Gan W.J., Mellett N.A., Das P.P., Weir J.M., Ditiatkovski M., RA Fynch S., Thorn P., Thomas H.E., Meikle P.J., Parkington H.C., Smyth I.M., RA Sviridov D.; RT "ABCA12 regulates insulin secretion from beta-cells."; RL EMBO Rep. 21:e48692-e48692(2020). RN [10] RP INDUCTION. RX PubMed=32873425; DOI=10.1016/j.jdermsci.2020.08.010; RA Teramura T., Nomura T.; RT "Acute skin barrier disruption alters the secretion of lamellar bodies via RT the multilayered expression of ABCA12."; RL J. Dermatol. Sci. 100:50-57(2020). CC -!- FUNCTION: Transports lipids such as glucosylceramides from the outer to CC the inner leaflet of lamellar granules (LGs) membrane, whereby the CC lipids are finally transported to the keratinocyte periphery via the CC trans-Golgi network and LGs and released to the apical surface of the CC granular keratinocytes to form lipid lamellae in the stratum corneum of CC the epidermis, which is essential for skin barrier function CC (PubMed:18957418, PubMed:27551807, PubMed:24293640, PubMed:20489143, CC PubMed:18802465). In the meantime, participates in the transport of the CC lamellar granules-associated proteolytic enzymes, in turn regulates CC desquamation and keratinocyte differentiation (PubMed:27551807, CC PubMed:20489143). Furthermore, is essential for the regulation of CC cellular cholesterol homeostasis by regulating ABCA1-dependent CC cholesterol efflux from macrophages through interaction with NR1H2 and CC ABCA1 (PubMed:18802465, PubMed:23931754). Plays pleiotropic roles in CC regulating glucose stimulated insulin secretion from beta cells, CC regulating the morphology and fusion of insulin granules, lipid raft CC abundance and the actin cytoskeleton (PubMed:32072744). Also involved CC in lung surfactant biogenesis (PubMed:18632686). CC {ECO:0000269|PubMed:18632686, ECO:0000269|PubMed:18802465, CC ECO:0000269|PubMed:18957418, ECO:0000269|PubMed:20489143, CC ECO:0000269|PubMed:23931754, ECO:0000269|PubMed:24293640, CC ECO:0000269|PubMed:27551807, ECO:0000269|PubMed:32072744}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + H2O + phospholipidSide 1 = ADP + phosphate + CC phospholipidSide 2.; EC=7.6.2.1; CC Evidence={ECO:0000250|UniProtKB:Q86UK0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + beta-D-glucosylceramide(in) + H2O = ADP + beta-D- CC glucosylceramide(out) + H(+) + phosphate; Xref=Rhea:RHEA:66660, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:83264, ChEBI:CHEBI:456216; CC Evidence={ECO:0000250|UniProtKB:Q86UK0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66661; CC Evidence={ECO:0000250|UniProtKB:Q86UK0}; CC -!- SUBUNIT: Interacts with NR1H2 and ABCA1; this interaction is required CC for ABCA1 localization to the cell surface and is necessary for its CC normal activity and stability. {ECO:0000269|PubMed:23931754}. CC -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane CC {ECO:0000250|UniProtKB:Q86UK0}; Multi-pass membrane protein CC {ECO:0000250|UniProtKB:Q86UK0}. Golgi apparatus membrane CC {ECO:0000250|UniProtKB:Q86UK0}. Note=Localizes in the limiting membrane CC of the lamellar granules (LGs). Trafficks from the Golgi apparatus to CC the lamellar granules (LGs) at the cell periphery in the uppermost CC granular layer keratinocytes where ABCA12-positive LGs fuse with the CC keratinocyte-cell membrane to secrete their lipid content to the CC extracellular space of the stratum corneum. Co-localizes through the CC Golgi apparatus to the cell periphery with glucosylceramide. CC {ECO:0000250|UniProtKB:Q86UK0}. CC -!- TISSUE SPECIFICITY: Expressed in a number of other tissues besides CC skin, including heart, intestine, stomach, and kidney CC (PubMed:24293640). Expressed mainly in the granular layer of the skin CC (PubMed:18632686). Expressed in lung (PubMed:18632686). Expressed in CC alpha and beta cells of pancreatic islets (PubMed:32072744). CC {ECO:0000269|PubMed:18632686, ECO:0000269|PubMed:24293640, CC ECO:0000269|PubMed:32072744}. CC -!- DEVELOPMENTAL STAGE: At 18.5 dpc highly expressed in the epidermis, and CC weakly in the stomach. {ECO:0000269|PubMed:24293640}. CC -!- INDUCTION: Up-regulated during barrier recovery. CC {ECO:0000269|PubMed:32873425}. CC -!- DOMAIN: Multifunctional polypeptide with two homologous halves, each CC containing a hydrophobic membrane-anchoring domain and an ATP binding CC cassette (ABC) domain. {ECO:0000250}. CC -!- DISRUPTION PHENOTYPE: Homozygous knockout mice for Abca12 are born with CC a thickened epidermis and die shortly after birth, as water rapidly CC evaporates from their skin (PubMed:18957418). In a mouse model for CC harlequin ichthyosis (HI), homozygous knockout mice are smaller and die CC within a few hours and their entire body are covered of erythematous CC skin, making their skin less flexible. The entire skin surface is CC covered with thick scales and some mice develop skin fissures and CC eversions of the lips (eclabium). At 18.5 dpc, fetuses develop taut and CC shiny skin without normal skin folds and show contractures of the CC limbs. The lungs of the present model mice show signs of alveolar CC collapse (PubMed:18632686). {ECO:0000269|PubMed:18632686, CC ECO:0000269|PubMed:18957418}. CC -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCA family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AC107789; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC138589; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS48286.1; -. DR RefSeq; NP_780419.2; NM_175210.3. DR AlphaFoldDB; E9Q876; -. DR SMR; E9Q876; -. DR STRING; 10090.ENSMUSP00000084523; -. DR GlyCosmos; E9Q876; 39 sites, No reported glycans. DR GlyGen; E9Q876; 39 sites. DR iPTMnet; E9Q876; -. DR PhosphoSitePlus; E9Q876; -. DR PaxDb; 10090-ENSMUSP00000084523; -. DR ProteomicsDB; 324613; -. DR Antibodypedia; 34220; 152 antibodies from 26 providers. DR DNASU; 74591; -. DR Ensembl; ENSMUST00000087268.7; ENSMUSP00000084523.6; ENSMUSG00000050296.15. DR GeneID; 74591; -. DR KEGG; mmu:74591; -. DR UCSC; uc011wmq.1; mouse. DR AGR; MGI:2676312; -. DR CTD; 26154; -. DR MGI; MGI:2676312; Abca12. DR VEuPathDB; HostDB:ENSMUSG00000050296; -. DR eggNOG; KOG0059; Eukaryota. DR GeneTree; ENSGT00940000157295; -. DR HOGENOM; CLU_000604_19_7_1; -. DR InParanoid; E9Q876; -. DR OMA; TYIVREH; -. DR OrthoDB; 6951at2759; -. DR PhylomeDB; E9Q876; -. DR TreeFam; TF105191; -. DR Reactome; R-MMU-1369062; ABC transporters in lipid homeostasis. DR BioGRID-ORCS; 74591; 2 hits in 80 CRISPR screens. DR ChiTaRS; Abca12; mouse. DR PRO; PR:E9Q876; -. DR Proteomes; UP000000589; Chromosome 1. DR RNAct; E9Q876; Protein. DR Bgee; ENSMUSG00000050296; Expressed in esophagus and 27 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; ISO:MGI. DR GO; GO:0005829; C:cytosol; IDA:MGI. DR GO; GO:0097209; C:epidermal lamellar body; ISO:MGI. DR GO; GO:0097234; C:epidermal lamellar body membrane; ISS:UniProtKB. DR GO; GO:0000139; C:Golgi membrane; ISS:UniProtKB. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central. DR GO; GO:0005743; C:mitochondrial inner membrane; HDA:MGI. DR GO; GO:0005886; C:plasma membrane; ISO:MGI. DR GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell. DR GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro. DR GO; GO:0034191; F:apolipoprotein A-I receptor binding; ISO:MGI. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro. DR GO; GO:0140326; F:ATPase-coupled intramembrane lipid transporter activity; IEA:UniProtKB-EC. DR GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IBA:GO_Central. DR GO; GO:0005319; F:lipid transporter activity; ISO:MGI. DR GO; GO:0005102; F:signaling receptor binding; ISO:MGI. DR GO; GO:0006672; P:ceramide metabolic process; IMP:UniProtKB. DR GO; GO:0035627; P:ceramide transport; IMP:UniProtKB. DR GO; GO:0033344; P:cholesterol efflux; IMP:MGI. DR GO; GO:0003336; P:corneocyte desquamation; IMP:UniProtKB. DR GO; GO:0051649; P:establishment of localization in cell; IMP:MGI. DR GO; GO:0061436; P:establishment of skin barrier; IMP:UniProtKB. DR GO; GO:0006886; P:intracellular protein transport; ISS:UniProtKB. DR GO; GO:0031424; P:keratinization; IMP:MGI. DR GO; GO:0030216; P:keratinocyte differentiation; IMP:MGI. DR GO; GO:0055088; P:lipid homeostasis; IMP:MGI. DR GO; GO:0006869; P:lipid transport; ISO:MGI. DR GO; GO:0048286; P:lung alveolus development; IMP:MGI. DR GO; GO:0033700; P:phospholipid efflux; ISO:MGI. DR GO; GO:0010875; P:positive regulation of cholesterol efflux; IMP:MGI. DR GO; GO:0032379; P:positive regulation of intracellular lipid transport; IMP:UniProtKB. DR GO; GO:2000010; P:positive regulation of protein localization to cell surface; IMP:MGI. DR GO; GO:0072659; P:protein localization to plasma membrane; ISO:MGI. DR GO; GO:0045055; P:regulated exocytosis; ISO:MGI. DR GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB. DR GO; GO:0045616; P:regulation of keratinocyte differentiation; IMP:UniProtKB. DR GO; GO:0032940; P:secretion by cell; ISO:MGI. DR GO; GO:0043129; P:surfactant homeostasis; IMP:MGI. DR CDD; cd03263; ABC_subfamily_A; 2. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2. DR InterPro; IPR003593; AAA+_ATPase. DR InterPro; IPR013525; ABC2_TM. DR InterPro; IPR003439; ABC_transporter-like_ATP-bd. DR InterPro; IPR017871; ABC_transporter-like_CS. DR InterPro; IPR026082; ABCA. DR InterPro; IPR027417; P-loop_NTPase. DR PANTHER; PTHR19229; ATP-BINDING CASSETTE TRANSPORTER SUBFAMILY A ABCA; 1. DR PANTHER; PTHR19229:SF29; GLUCOSYLCERAMIDE TRANSPORTER ABCA12; 1. DR Pfam; PF12698; ABC2_membrane_3; 2. DR Pfam; PF00005; ABC_tran; 2. DR SMART; SM00382; AAA; 2. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2. DR PROSITE; PS00211; ABC_TRANSPORTER_1; 1. DR PROSITE; PS50893; ABC_TRANSPORTER_2; 2. DR Genevisible; E9Q876; MM. PE 1: Evidence at protein level; KW ATP-binding; Cytoplasmic vesicle; Glycoprotein; Golgi apparatus; KW Lipid transport; Membrane; Nucleotide-binding; Reference proteome; Repeat; KW Translocase; Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..2595 FT /note="Glucosylceramide transporter ABCA12" FT /id="PRO_0000452550" FT TRANSMEM 23..43 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1062..1082 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1109..1129 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1142..1162 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1171..1191 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1197..1217 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1247..1267 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1747..1767 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1979..1999 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2035..2055 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2072..2092 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2103..2123 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2143..2163 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2187..2207 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 2270..2290 FT /note="Helical" FT /evidence="ECO:0000255" FT DOMAIN 1346..1577 FT /note="ABC transporter 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT DOMAIN 2254..2489 FT /note="ABC transporter 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT REGION 109..143 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1672..1703 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2575..2595 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 115..139 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 1378..1385 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT BINDING 2290..2297 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT CARBOHYD 120 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 156 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 174 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 214 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 275 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 331 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 365 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 381 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 410 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 433 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 455 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 526 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 541 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 574 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 605 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 645 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 749 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 773 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 812 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 823 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 854 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 917 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 960 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1167 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1319 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1524 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1663 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1673 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1686 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1690 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1704 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1819 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1835 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1876 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1921 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1952 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2318 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2542 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2547 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT MUTAGEN 1388..1461 FT /note="ISMLTGLFGATAGTIFVYGKDIKTDLNTVRKNMGVCMQHDVLFSYLTTKEHL FT LLYGSIKVPHWTKTQLHEEVKR->M: In a mouse model for harlequin FT ichthyosis (HI), smooth skin (smsk) mutant mice show a FT pronounced perinatal lethal skin phenotype in 25% of the FT offspring and newborn mutant pups die within a few hours FT after birth, and appear severely dehydrated with dry FT cracking skin. Smsk homozygous mutants embryos show a FT normal appearance at 14.5 dpc, but at 16.5 dpc develop a FT partial absence of normal skin folds around the trunk and FT limbs, and by 18.5 dpc develop a taut, thick skin and limb FT contractures." FT /evidence="ECO:0000269|PubMed:27551807" FT MUTAGEN 1996 FT /note="G->D: In a mouse model for harlequin ichthyosis FT (HI), homozygous mice are embryonic lethal but occasionally FT pups are found in the first few hours after birth but die FT and are severely dehydrated and fail to suckle normally. FT Homozygous pups show hallmarks of HI desease including FT hyperkeratosis, abnormal extracellular lipid lamellae and FT defects in cornified envelope processing. At 14.5 dpc and FT 15.5 dpc homozygous embryos appear normal; however from FT 16.5 dpc onwards they are characterized by an absence of FT normal skin folds around the trunk and limbs. As FT development progressed, embryos develop a taut, thick FT epidermis and multiple contractures affecting the limbs. FT Late stage embryos are smaller." FT /evidence="ECO:0000269|PubMed:18802465" SQ SEQUENCE 2595 AA; 292592 MW; 17D651731EC35D05 CRC64; MASQFHQLRI LVWKNWLGVK RQPLWTLVLI LWPVIIFIIL AITRTKFPPT AKPTCYLAPR NLPSAGFFPF LQTLLCDTDS KCKDTPYGPR DLLRRKGIDG PLFKESEILK KPSNPKRDSN LSLRSTQVPE RSHTSLATVP PRPSYDLEGT GTENFNGSQL LTRILGLEKL LKQNSTPEDI RRELCESYPG YTADYAFSWV TLGKNVFNKF CLSNMTLLES SLQELKYQVS QMSSDPDNQK RVFRGLVQVL SFFSQVQQQR EVWQLLSSLP DVFQNGTSLS SLFGVLQKAN RVLLVVQKVY PRVQTDEGFS TLQKSVKHLL NTLDSPMQGD NSTHAWSDDD EQTLSPSSLA AQLLILENFE DAILNISSNS PYSPYLACVR NMTDNLAKGS PDNLKLLQST IHFRKSFLQN GSSEDSFPPF LEILKSKLSQ LRNLTELLCE SETFSSIKKS CQFSNMSFER LCEDHAFHVQ LIEAAELGTD LTTGLLYHDN IISAKLRGLL TGDPSKINLN VDWLLEQALQ MNYLENITRL IPTVEAMLHV NTSADASEKP GQLREMFKNI DLLKEDLRAI GMSNTSIDKL LAIPIPDNRA EIISRVFWLH SCDTNVTNPK LEDAMKEFCK LPLPERSHQS YLIGLTLLHY LDIYNFTYKV FFPRKDQKPM ERMMELFIKL REILNQLASG THPLLDKMRS LRQMHLPRSV PLTQAMYRNT RMNSPAGSFS TISQALCSQG ITTEYLTAML PSSQKPKGNH TKDFLTYKLT KEEIASKYGI PLNATPFCFS LYKDIINMPA GPVIWAFLKP MLLGKILYSP YNPTTKAIME KSNVTLRQLA ELREKSQEWM DKSPIFMNSF HLLNQTIPML QNTLRNPFVQ VFVKFSVGLD AVELLKQIDD LDVLRLKLVN NIDIIDQLNT LSSLTVNISS CVLYDRIQAS DTVEEMETVA EQLYKSNELF GSVIFKLPSN GSLHRGFDPE KVSLPPIVRY TIRMSLKTAQ TTRSIRTKIW APGPHNSPSH NQIYGRAFIY LQDSIERAII ELQTGRNSQE VAVQVQAVPY PCFMKDNFLT SVSYSLPIVL MVAWVVFIAA FVKKLVYEKD LRLHEYMKMM GVNSCSHFFA WLIESIGFLL VTIAILIVIL KFGNILPKTN GFILFLYFSD YSFSVIAMSY LISVFFNNTN IAALIGSLIY VIAFFPFIVL VTVEDELSYV IKVFMSLLSP TAFSYASQYI ARYEEQGVGL QWENMYKSPV QDDTTSFGWL CCLILADSFI YFFIAWYVRN VFPGTYGMAA PWYFPILPSY WKERFGCAEV KHEKSNGLMF TNIMMQNTNP SASKTSPDCA FPSNIEPEPK DLQVGVALHG VTKIYGSKTA VENLNLNFYE GHITSLLGPN GAGKTTTISM LTGLFGATAG TIFVYGKDIK TDLNTVRKNM GVCMQHDVLF SYLTTKEHLL LYGSIKVPHW TKTQLHEEVK RTLKDTGLYS HRHKRVGTLS GGMKRKLSIS IALIGGSRVV ILDEPSTGVD PCSRRSIWDV ISKNKTARTI ILSTHHLDEA EVLSDRIAFL EQGGLRCCGS PFYLKEAFGD GYHLTLTKKK SPNLDTNAIC DTVAVTAMIQ SHLPEAYLKE DIGGELVYVL PPFSTKVSGA YLSLLRALDK GMGKLNIGCY GISDTTVEEV FLNLTKDSQK SSNMSLEHLT QRKVGNPSAN GTSTPDDLSV SSSNFTDRDD KVLTRSEKLE GFGLLLKKIM AILIKRFHHT RRNWKGLIAQ VILPIVFVAT AMGLGTLRDS SNSYPEIMIS PSIYGTSEQT AFYANFDPST SGLVSALWNF PGIDNVCLNT SDLQCLKKDD LGKWNTSGEA IDNFGVCSCS DNVQECPKFN YHPPHRRTYS SQVIYNLTGK HMENYLITTA NHFVQKRYGG WSFGMKLTND LRFDVTAVPD NRTLAKVWYD PEGYHSLPAY LNSLNNFLLR VNMSEYDAAR HGIIMYSHPY PGVQDQEQAT ISSLIDILVA LSILMGYSVT TASFVTYIVR EHQTKAKQLQ HISGIGVTCY WVTNFIYDMV FYLVPVAFSI GVIAIFKLPA FYSGNNLGAV SLLLLLFGYA TFSWMYLLAG LFHETGMAFI TYVCVNLFFG INSIVSLSVV YFLSKEKPND PTLELISETL KRIFLIFPQF CFGYGLIELS QQQAVLDFLK AYGVEYPSET FEMDKLGAMF VALVSQGTMF FLLRLLINEW LIKKLRLFFR KFTSSPIMET VDEDEDVRAE RFRVESGAAE FDLVQLHRLT KTYQLIHKKI IAVNNISLGI PAGECFGLLG VNGAGKTTIF KMLTGDIIPS SGNILIRNKS GSLGHVDSHS SLVGYCPQED ALDDLVTVEE HLYFYARVHG IPEKDIKDTV HKLLRRLHLM AYKDRSTSMC SYGTKRKLST ALALIGKPSI LLLDEPSSGM DPKSKRHLWR IISEEVQNKC SVILTSHSME ECEALCTRLA IMVNGRFQCI GSLQHIKSRF GRGFTVKVHL KNNKVSMETL TKFMQLHFPK TYLKDQHLSM LEYHVPVTAG GVANIFDLLE TNKTALNITN FLVSQTTLEE VFINFAKDQK SYENVDTSSQ GSTISVDSQE DQLDS //